Insight Molecular Diagnostics (IMDX) Price & Analysis

Compare

427 Followers

IMDX Stock Chart & Stats

Day’s Range― - ―

52-Week Range$1.92 - $4.75

Previous CloseN/A

VolumeN/A

Average Volume (3M)40.60K

Market Cap

$74.13M

Enterprise Value$75.80M

Total Cash (Recent Filing)$24.29M

Total Debt (Recent Filing)$3.37M

Price to Earnings (P/E)―

Beta0.45

Next Earnings

Nov 06, 2025

EPS Estimate

-0.21

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.30

Shares Outstanding28,619,750

10 Day Avg. Volume34,341

30 Day Avg. Volume40,599

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.02

Enterprise Value/Revenue17.81

Enterprise Value/Gross Profit28.07

Enterprise Value/Ebitda-1.22

Forecast

1Y Price Target

$6.13

Price Target Upside136.68% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Growth OpportunitiesPlans for GraftAssureDx suggest future growth opportunities for OncoCyte.

Market StrategyOncocyte has an ambitious plan to upend the current market for transplant rejection testing using donor-derived cell-free DNA (dd-cfDNA).

Product LaunchThe GraftAssure RUO launch is a key topic of discussion, indicating a positive development for OncoCyte.

Bears Say

Financial ChallengesCash use is a significant topic of discussion, indicating potential financial challenges for OncoCyte.

Stock PerformanceShares have traded down 66% since Josh Riggs took the helm on an interim basis.

Tariff ExposureTariff exposure is a concern that could negatively impact OncoCyte.

Insight Molecular Diagnostics News

IMDX’s GraftAssureDx Study: A Game-Changer in Kidney Transplant Monitoring?

Insight Molecular Diagnostics Inc. (($IMDX)) announced an update on their ongoing clinical study. Study Overview: Insight Molecular Diagnostics...

11d ago

IMDX

Insight Molecular Diagnostics: Promising Future with GraftAssureIQ and Strategic Expansion

Analyst Michael Matson of Needham maintained a Buy rating on Insight Molecular Diagnostics, retaining the price target of...

14d ago

IMDX

Insight Molecular Diagnostics Reports Q2 2025 Progress

OncoCyte Corp ( ($IMDX) ) has released its Q2 earnings. Here is a breakdown of the information OncoCyte...

14d ago

IMDX

OCX Earnings this Week: How Will it Perform?

OncoCyte Corp (OCX) is scheduled to report 2nd quarter earnings on 08/11/2025, after the market closes. Regarding Q2...

17d ago

IMDX

Insight Molecular Diagnostics Approves Key Proposals at Annual Meeting

Insight Molecular Diagnostics ( ($IMDX) ) just unveiled an update. On June 27, 2025, Insight Molecular Diagnostics Inc....

2M ago

IMDX

Insight Molecular Diagnostics announces results from test kit technology study

Insight Molecular Diagnostics (IMDX) announced results from a study evaluating its test kit technology in a head-to-head comparison...

2M ago

IMDX

IMDX FAQ

What was Insight Molecular Diagnostics’s price range in the past 12 months?

Insight Molecular Diagnostics lowest stock price was $1.92 and its highest was $4.75 in the past 12 months.

What is Insight Molecular Diagnostics’s market cap?

Insight Molecular Diagnostics’s market cap is $74.13M.

When is Insight Molecular Diagnostics’s upcoming earnings report date?

Insight Molecular Diagnostics’s upcoming earnings report date is Nov 06, 2025 which is in 72 days.

How were Insight Molecular Diagnostics’s earnings last quarter?

Insight Molecular Diagnostics released its earnings results on Aug 11, 2025. The company reported -$0.3 earnings per share for the quarter, missing the consensus estimate of -$0.23 by -$0.07.

Is Insight Molecular Diagnostics overvalued?

According to Wall Street analysts Insight Molecular Diagnostics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Insight Molecular Diagnostics pay dividends?

Insight Molecular Diagnostics does not currently pay dividends.

What is Insight Molecular Diagnostics’s EPS estimate?

Insight Molecular Diagnostics’s EPS estimate is -0.21.

How many shares outstanding does Insight Molecular Diagnostics have?

Insight Molecular Diagnostics has 28,619,750 shares outstanding.

What happened to Insight Molecular Diagnostics’s price movement after its last earnings report?

Insight Molecular Diagnostics reported an EPS of -$0.3 in its last earnings report, missing expectations of -$0.23. Following the earnings report the stock price went down -3.831%.

Which hedge fund is a major shareholder of Insight Molecular Diagnostics?

Currently, no hedge funds are holding shares in IMDX

Insight Molecular Diagnostics Stock Smart Score

Underperform

Fundamentals

Return on Equity

-532.89%

Trailing 12-Months

Asset Growth

-32.39%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Insight Molecular Diagnostics

Insight Molecular Diagnostics (IMDX) is a biotechnology company specializing in the development of molecular diagnostic tests for infectious diseases and other health conditions. The company focuses on leveraging advanced technologies to improve patient outcomes through accurate and timely diagnostics. IMDX's core products include a range of molecular assays designed for use in clinical laboratories, enabling healthcare providers to make informed decisions based on precise genetic and pathogen information.

Insight Molecular Diagnostics (IMDX) Earnings & Revenues

Historic Earnings Reports

IMDX Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call reflects a company making solid progress with its FDA submission and assay improvements, supported by strong engagement with transplant centers and a high positive predictive value achievement. However, these positive developments are tempered by challenges in revenue generation and clinical trial enrollment.View all IMDX earnings summaries

IMDX Stock 12 Month Forecast

Average Price Target

$6.13

▲(136.68% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","3":"$3","5":"$5","7":"$7","9":"$9"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$8.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$6.13</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.25,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.25</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3,5,7,9],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.56,2.9784615384615387,3.396923076923077,3.815384615384615,4.233846153846153,4.6523076923076925,5.070769230769231,5.489230769230769,5.907692307692308,6.326153846153845,6.7446153846153845,7.163076923076924,7.581538461538461,{"y":8,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.56,2.8346153846153848,3.109230769230769,3.3838461538461537,3.6584615384615384,3.933076923076923,4.207692307692308,4.4823076923076925,4.756923076923076,5.031538461538462,5.306153846153846,5.5807692307692305,5.855384615384615,{"y":6.13,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.56,2.69,2.8200000000000003,2.95,3.08,3.21,3.34,3.47,3.6,3.73,3.8600000000000003,3.99,4.12,{"y":4.25,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.55,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.11,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.14,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.99,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.45,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.38,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.8,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.19,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.04,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.56,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >